Cargando…
Validation studies of outcome measures in pemphigus()()()
Pemphigus is a group of rare and potentially fatal autoimmune blistering diseases that are associated with auto-antibodies that target intercellular adhesion molecules. Incidence of pemphigus varies among populations, with the lowest incidence in Switzerland and Finland at 0.6–0.76 per million per y...
Autores principales: | Hanna, Sarah, Kim, Minhee, Murrell, Dedee F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419045/ https://www.ncbi.nlm.nih.gov/pubmed/28492025 http://dx.doi.org/10.1016/j.ijwd.2016.10.003 |
Ejemplares similares
-
Management of pemphigus
por: Daniel, Benjamin S., et al.
Publicado: (2014) -
Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
por: Patsatsi, Aikaterini, et al.
Publicado: (2021) -
Treatment considerations for patients with pemphigus during the COVID-19 pandemic
por: Shakshouk, Hadir, et al.
Publicado: (2020) -
New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature()()
por: Xuan, Rachel R., et al.
Publicado: (2018) -
Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review
por: Zeng, Faith A.P., et al.
Publicado: (2022)